InSysBio to take part in ACoP13

events
Conference
October 12, 2022

October 12, 2022

InSysBio announces its participation in the Thirteenth American Conference on Pharmacometrics (ACoP13) which is to be held in person from October 30th to November 2nd, 2022, at the Gaylord Rockies Resort & Convention Center in Aurora, Colorado. The theme of ACoP13 is “Together Moving Mountains”. InSysBio team is going to present 7 posters in frames of the Conference, namely:

Monday, October 31

  • M-006: "Virtual Patients Parallel Simulations in a Hybrid Cloud Environment" by Ivan Borisov, Evgeny Metelkin, Tatiana Karelina, Oleg Demin
  • M-057: "Quantitative systems pharmacology model for neurofilament L dynamics in multiple sclerosis and under immunomodulatory therapies" by Polina Pchelintseva

Tuesday, November 1

  • T-040: "Quantitative systems pharmacology modeling of immune response role in Parkinson’s disease" by Tatiana Karelina
  • T-051: "Methodological aspects of rate law derivation of cell dynamics processes: focus on QSP model development" by Oleg Demin, Maria Mironovich, Julia Sergienko
  • T-054: "Estimation of Imax and IC50 for PD1-PDL1 inhibition of T cell proliferation" by Oleg Demin
  • T-061: "The QSP model of microglia role in tau pathology and neurodegeneration" by Stepan Lerner
  • T-065: "Pharmacokinetics modeling and optimal dose prediction for a bispecific antibody against CD40 and PD1" by Alexandra Diakonova, Oleg Demin Jr, Dmitry Shchelokov, Oleg Demin

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Edinburgh, UK (INSYSBIO UK LIMITED), Cyprus (INSYSBIO CY Ltd) and Moscow, Russia (INSYSBIO LLC). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

 

October 2022
MoTuWeThFrSaSu
     
1
2
3
4
5
6
7
8
9
10
11
12
1. 12 Oct 2022 16:07 InSysBio to take part in ACoP13 InSysBio announces its participation in the Thirteenth American Conference on Pharmacometrics (ACoP13) which is to be held in person from October 30th to November 2nd, 2022, at the Gaylord Rockies Resort & Convention Center in Aurora, Colorado. InSysBio team is going to present 7 posters in frames of the Conference
13
14
15
16
17
18
19
20
21
22
23
24
25
1. 25 Oct 2022 14:41 InSysBio to present its ePoster at ECTRIMS 2022 InSysBio team is going to present its poster in frames of 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis which is to be held October 26-28, Amsterdam, the Netherlands. The ePoster is going to be presented in frames of "Pathology and pathogenesis of MS - Neurodegeneration" ePoster Area, October 26
26
27
28
29
30
31
      
Upcoming Events
Tags
Latest News
09.11
InSysBio to start the operation of new Headquarters and new branch office
11.07
InSysBio team to publish the new article in Journal of Pharmacokinetics and Pharmacodynamics
24.05
InSysBio to establish a new legal entity in Cyprus
25.04
InSysBio's ASCPT 2022 Micro-Theater Session on YouTube
20.01
InSysBio to release Immune Response Template v. 3.6.0